These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 17712550

  • 1. Analysis of O-glycan heterogeneity in IgA1 myeloma proteins by Fourier transform ion cyclotron resonance mass spectrometry: implications for IgA nephropathy.
    Renfrow MB, Mackay CL, Chalmers MJ, Julian BA, Mestecky J, Kilian M, Poulsen K, Emmett MR, Marshall AG, Novak J.
    Anal Bioanal Chem; 2007 Nov; 389(5):1397-407. PubMed ID: 17712550
    [Abstract] [Full Text] [Related]

  • 2. Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry.
    Renfrow MB, Cooper HJ, Tomana M, Kulhavy R, Hiki Y, Toma K, Emmett MR, Mestecky J, Marshall AG, Novak J.
    J Biol Chem; 2005 May 13; 280(19):19136-45. PubMed ID: 15728186
    [Abstract] [Full Text] [Related]

  • 3. Clustered O-glycans of IgA1: defining macro- and microheterogeneity by use of electron capture/transfer dissociation.
    Takahashi K, Wall SB, Suzuki H, Smith AD, Hall S, Poulsen K, Kilian M, Mobley JA, Julian BA, Mestecky J, Novak J, Renfrow MB.
    Mol Cell Proteomics; 2010 Nov 13; 9(11):2545-57. PubMed ID: 20823119
    [Abstract] [Full Text] [Related]

  • 4. Elucidating heterogeneity of IgA1 hinge-region O-glycosylation by use of MALDI-TOF/TOF mass spectrometry: role of cysteine alkylation during sample processing.
    Franc V, Řehulka P, Raus M, Stulík J, Novak J, Renfrow MB, Šebela M.
    J Proteomics; 2013 Oct 30; 92():299-312. PubMed ID: 23891555
    [Abstract] [Full Text] [Related]

  • 5. Mass spectrometry analysis of IgA1 hinge region in patients with IgA nephropathy.
    Gastaldi D, Paradisi L, Baiocchi C, Medana C, Lo Duca G, Sena LM, Roccatello D.
    J Nephrol; 2007 Oct 30; 20(6):689-95. PubMed ID: 18046671
    [Abstract] [Full Text] [Related]

  • 6. O- and N-Glycosylation of Serum Immunoglobulin A is Associated with IgA Nephropathy and Glomerular Function.
    Dotz V, Visconti A, Lomax-Browne HJ, Clerc F, Hipgrave Ederveen AL, Medjeral-Thomas NR, Cook HT, Pickering MC, Wuhrer M, Falchi M.
    J Am Soc Nephrol; 2021 Oct 30; 32(10):2455-2465. PubMed ID: 34127537
    [Abstract] [Full Text] [Related]

  • 7. Naturally occurring structural isomers in serum IgA1 o-glycosylation.
    Takahashi K, Smith AD, Poulsen K, Kilian M, Julian BA, Mestecky J, Novak J, Renfrow MB.
    J Proteome Res; 2012 Feb 03; 11(2):692-702. PubMed ID: 22067045
    [Abstract] [Full Text] [Related]

  • 8. IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells.
    Novak J, Moldoveanu Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J.
    Contrib Nephrol; 2007 Feb 03; 157():134-8. PubMed ID: 17495451
    [Abstract] [Full Text] [Related]

  • 9. Separation of Two Distinct O-Glycoforms of Human IgA1 by Serial Lectin Chromatography Followed by Mass Spectrometry O-Glycan Analysis.
    Lehoux S, Ju T.
    Methods Enzymol; 2017 Feb 03; 585():61-75. PubMed ID: 28109443
    [Abstract] [Full Text] [Related]

  • 10. Analysis of O-glycoforms of the IgA1 hinge region by sequential deglycosylation.
    Ohyama Y, Yamaguchi H, Nakajima K, Mizuno T, Fukamachi Y, Yokoi Y, Tsuboi N, Inaguma D, Hasegawa M, Renfrow MB, Novak J, Yuzawa Y, Takahashi K.
    Sci Rep; 2020 Jan 20; 10(1):671. PubMed ID: 31959827
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the specific structures of IgA1 hinge glycopeptide in 30 IgA nephropathy patients by mass spectrometry.
    Odani H, Yamamoto K, Iwayama S, Iwase H, Takasaki A, Takahashi K, Fujita Y, Sugiyama S, Hiki Y.
    J Nephrol; 2010 Jan 20; 23(1):70-6. PubMed ID: 20091489
    [Abstract] [Full Text] [Related]

  • 12. Difference in IgA1 O-glycosylation between IgA deposition donors and IgA nephropathy recipients.
    Nakazawa S, Imamura R, Kawamura M, Kato T, Abe T, Namba T, Iwatani H, Yamanaka K, Uemura M, Kishikawa H, Nishimura K, Oka K, Tajiri M, Wada Y, Nonomura N.
    Biochem Biophys Res Commun; 2019 Jan 22; 508(4):1106-1112. PubMed ID: 30553446
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy.
    Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K.
    Kidney Int; 2001 Mar 22; 59(3):1077-85. PubMed ID: 11231363
    [Abstract] [Full Text] [Related]

  • 15. IgA nephropathy: characterization of IgG antibodies specific for galactose-deficient IgA1.
    Suzuki H, Moldoveanu Z, Hall S, Brown R, Julian BA, Wyatt RJ, Tomana M, Tomino Y, Novak J, Mestecky J.
    Contrib Nephrol; 2007 Mar 22; 157():129-33. PubMed ID: 17495450
    [Abstract] [Full Text] [Related]

  • 16. Pathogenic role of glycan-specific IgG antibodies in IgA nephropathy.
    Zhao YF, Zhu L, Liu LJ, Shi SF, Lv JC, Zhang H.
    BMC Nephrol; 2017 Sep 29; 18(1):301. PubMed ID: 28969604
    [Abstract] [Full Text] [Related]

  • 17. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry.
    Odani H, Hiki Y, Takahashi M, Nishimoto A, Yasuda Y, Iwase H, Shinzato T, Maeda K.
    Biochem Biophys Res Commun; 2000 Apr 29; 271(1):268-74. PubMed ID: 10777713
    [Abstract] [Full Text] [Related]

  • 18. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.
    Adv Otorhinolaryngol; 2011 Apr 29; 72():60-3. PubMed ID: 21865691
    [Abstract] [Full Text] [Related]

  • 19. Changes in the expression of N- and O-glycopeptides in patients with colorectal cancer and hepatocellular carcinoma quantified by full-MS scan FT-ICR and multiple reaction monitoring.
    Darebna P, Novak P, Kucera R, Topolcan O, Sanda M, Goldman R, Pompach P.
    J Proteomics; 2017 Feb 05; 153():44-52. PubMed ID: 27646713
    [Abstract] [Full Text] [Related]

  • 20. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J, Allen AC.
    J Nephrol; 1999 Feb 05; 12(2):59-65. PubMed ID: 10378660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.